FEED
ENvue Medical, Inc.
1W: +97.0%
1M: +0.8%
3M: -15.0%
YTD: +8.6%
$2.17
-0.47 (-17.91%)
After Hours: $2.27 (+0.10, +4.74%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.9M
52W Range1.0046-5.98
Volume21,636,434
Avg Volume10,420,083
Beta2.28
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODoron Robert Besser
Employees31
SectorHealthcare
IndustryMedical - Specialties
IPO Date2025-12-12
Websitenanovibronix.com
Tyler 80333
US
1 914 233 3004
About ENvue Medical, Inc.
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.
Latest News
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| BANK OF AMERICA CORP | 0 | — | 2026-02-02 | |
| BANK OF AMERICA CORP | S-Sale | 100 | $3.05 | 2026-02-02 |
| BANK OF AMERICA CORP | S-Sale | 10 | $3.05 | 2026-02-02 |
| BANK OF AMERICA CORP | S-Sale | 4 | $3.05 | 2026-02-02 |
| BANK OF AMERICA CORP | S-Sale | 4 | $3.05 | 2026-02-02 |